Literature DB >> 4986441

Properties of 4-methylumbelliferyl-beta-galactosidase activities in human liver.

B Hultberg, P A Ockerman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4986441     DOI: 10.3109/00365516909077651

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  7 in total

1.  GM1 gangliosidosis in skin fibroblast culture: enzymatic differences between types 1 and 2 and observations on a third variant.

Authors:  L Pinsky; J Miller; B Shanfield; G Watters; L S Wolfe
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

2.  Purified human liver acid beta-D-galactosidases possessing activity towards G(M1)-ganglioside and lactosylceramide.

Authors:  A L Miller; R G Frost; J S O'Brien
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

3.  The stability and aggregation properties of human liver acid beta-D-galactosidase.

Authors:  C M Heyworth; E F Neumann; C H Wynn
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

4.  The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver.

Authors:  P S Cheetham; N E Dance
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

5.  Corneal clouding in GM1-generalized gangliosidosis.

Authors:  A Babarik; P F Benson; A H Fensom
Journal:  Br J Ophthalmol       Date:  1976-08       Impact factor: 4.638

6.  Rat small-intestinal beta-galactosidases. Studies on the fractionation of "acid" beta-galactosidase with isoelectric focusing, gel filtration and ion-exchange chromatography.

Authors:  N G Asp
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

7.  Gargoylism: hydrolysis of beta-galactosides and tissure accumulation of galactose- and mannose-containing compounds.

Authors:  B Hultberg; P A Ockerman; A Dahlqvist
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.